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Abstract
Background: The aim of our study is to compare the effects of thoracic epidural analgesia combined with general
anesthesia (GA) vs. general anesthesia on oxygenation and pulmonary shunt fraction during one-lung ventilation
(OLV).
Methods: Literature research was firstly conducted for studies related to comparison of epidural anesthesia
combined with GA vs. GA with reporting of hemodynamic and oxygenation variables and published from Jan 1990
to Jan 2014 in EMBAS, MEDLINE and Cochrane Central Register of Controlled Trials databases. The studies were
reviewed and data were extracted and analyzed using fixed-effect and random-effect models.
Results: There are 14 trials with 60 separate comparisons enrolling 653 patients for analysis. Regarding systemic
hemodynamics, thoracic epidural analgesia decreased the mean arterial pressure and mean pulmonary arterial
pressure with weighted mean difference 95 % confidence interval (−6.64 [−9.57 to −3.71] vs. -6.33 [−9.25 to −3.41]
and −3.18 [−5.07 to −1.28] vs. -2.05 [−3.35 to −0.75]) respectively at the two measurements time, however, only
decreasing heart rate and systemic vascular resistance (−3.28 [−5.98 to −0.67] and −319.99 [−447.05 to −192.94])
over the first 30 min after OLV. For oxygenation variables, thoracic epidural analgesia is associated with significant
reduction in partial arterial oxygen pressure, mixed arterial saturation of oxygenation and increased pulmonary
venous admixture fraction compared to general anesthesia with weighted mean difference 95 % confidence
interval (−16.52 [−21.98 to − 11.05] vs. − 14.23 [−20.81 to − 7.65]), (0.74 [0.33 to 1.15] vs. − 0.63 [−1.23 to −0.04]) and
(2.53 [1.35 to 3.72] vs. 2.77 [1.81 to 3.74]) respectively before and after 30 min of one-lung ventilation. A decrease in
mixed venous saturation of oxygenation occurred after 30 min of OLV (−2.39 [−3.73 to −0.99]). Besides, a higher
mean value of airway pressure was found in the thoracic epidural analgesia with weighted mean difference 95 %
confidence interval (1.95 [1.61 to 2.28] vs. 0.87 [0.54 to 1.20]) at the measurements.
Conclusion: Based on the existing limited data puts forward recommendations for cautious usage of thoracic
epidural analgesia in case of underlying risks in lower systemic hemodynamics, decreased partial arterial oxygen
pressure but increases pulmonary shunt during one-lung ventilation.
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Background
One-lung ventilation (OLV) in the lateral position is the
unique character of the thoracic surgery. During the
procedure, with a potential risk of increased pulmonary
shunt and occurrence of hypoxemia, the physiologic
defense mechanism, termed hypoxic pulmonary vaso-
constriction (HPV), starts with a rapid onset [1]. HPV is
generally considered to be a factor of governing the re-
distribution of blood flow to prevent partial arterial oxy-
gen pressure (PaO2) from excessively decreasing and to
optimize pulmonary gas exchange during OLV. This
physiologic response may be altered by many factors and
the effects on oxygenation or HPV should be taken into
consideration when choosing the anesthetic regimen. It
was suggested that the usage of thoracic epidural
anesthesia (TEA) may provide adequate analgesia, re-
duce postoperative mortality, improve pulmonary out-
comes and facilitate fast-track approach for patients
undergoing thoracic surgery [2–4]. Currently, continu-
ous TEA combined with general anesthesia has been
recommended widely in patients undergoing thoracic
surgery. Due to the fact that pulmonary vasculature is
dominant in sympathetic tone, it may be influenced by
segmental blocking the activity of the sympathetic sys-
tem over the vascular pulmonary responses. However,
experimental and clinical studies on controversial effects
of TEA with local anesthetics or opioids on HPV re-
sponse during OLV are rare [5–7]. The optimal
anesthetic management during OLV has not been yet
clearly determined. Therefore, our meta-analysis is aim-
ing to address this issue based on studies published over
15 years.
Methods
All experimental procedures listed below were approved
by the Ethics Committee of China Medical University
and were performed in accordance with the Helsinki
Declaration for Medical Research Involving Human
Subjects (the World Medical Association, Finland,
created in 1964 and revised 2013).
Literature review
This meta-analysis was performed with a prospective
protocol (outline below) using recommended literature
search strategies incorporating multiple search terms.
The literature search was performed in EMBAS, MED-
LINE and the Cochrane central register of Controlled
Trials databases published from Jan 1990 to Jan 2014 for
the trials related to thoracic epidural anesthesia. Thor-
acic epidural analgesia, thoracic epidural block or ‘epi-
dural-general’ were combined with procedure specific
search terms (one-lung ventilation, intrapulmonary
shunt) and limited by Human and Clinical trials. For the
TEA portion, MESH term thorax, epidural, anesthesia
AND text word thoracic epidural anesthesia were used
and combined with OR (n = 1603). MESH term thorax,
analgesia, epidural and the word thoracic epidural anal-
gesia were used and combined with OR (n = 1292).
MESH term lung, ventilation, respiration and text word
one lung ventilation were used to search the database
and combined with the term OR (7902). The primary in-
vestigations of 14 trials were acquired when all search
terms were combined with the term AND. Each was
then further checked by another two authors for any
additional studies, as were the author’s personal files for
additional references that met all inclusion criteria.
Study inclusion criteria
Thoracic epidural anesthesia (TEA) is defined as medi-
cine delivered into the thoracic epidural space by injec-
tion or repeated bolus dosing local anesthetics (LA) or
opioids. Studies given only a single epidural dose at the
beginning or end of surgery (single shot) were not
included.
Among all trials included in our meta-analysis, adult
patients (aged > =18 years) were randomly assigned to
one of the two groups: general intravenous or inhalation
anesthesia (GA group); general anesthesia combined
with TEA (TEA group). The observed variables are the
hemodynamic changes, arterial and mixed venous blood
gas analysis and the effects of on intrapulmonary shunt
fraction during OLV. Non-English language reports were
excluded.
Methodological qualities of included studies are
graded using Cochrane scoring systems with a 5-point
scale, in which a score of 1 is given for each of the
following: 1) the description of the study as random-
ized, 2) the description of an appropriate method of
randomization, 3) the description of the study as
double-blinded, 4) the description of an appropriate
method of double-blinding and 5) a statement of
withdraws. Since nonrandomized studies are excluded,
the minimum score is one and the maximum is five.
However, there are very few studies completely satis-
fied with all the criteria above. Hence, good-quality stud-
ies (prospective, randomized, and controlled) are
included without weight by sample size. Any disputes
were resolved by agreement of at least two reviewers
Data extraction and statistical analysis
Study information was summarized and listed in Table 1.
The comparisons of intraoperatively hemodynamic pa-
rameters, blood gas analysis and secondary outcomes
calculated by the standard formulas, such as mixed ven-
ous blood gas analysis and pulmonary shunt fraction
during OLV are included. The comparisons in trials were
then analyzed independently. Patients were subgrouped
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Table 1 Included randomized controlled trials for effects of thoracic epidural analgesia on oxygenation and pulmonary shunt
fraction during One-lung ventilation
Study Participants Interventions Abstracted outcomes
Ozcan
et al [5]
25 G-TIVA G-TIVA/ISO: induced: fentanyl (3 μg.kg−1), propofol
(BIS < 45) , vecuronium (0.1 mg.kg−1)




Maintained: propofol or isoflurane respectively
(according to BIS value)
25 G-ISO G-TIVA/ISO-TEA: T7-T8 epidural with initial 2 % lidocaine
2 mL ,0.1 % bupivacaine +0.1 mg.kg−1 morphine 10 mL,
then induced the same as G-TIVA/ISO group
25 G-ISO-
TEA
Maintained: 0.1 % bupivacaine +0.1 mg.kg−1 morphine
7 ml.h-1, and maintained with propofol or isoflurane
respectively (according to BIS value)
Garutti
et al. [6]
30 G-TIVA G-TIVA: induced: fentanyl (3 μg.kg−1), midazolam
(2-3 mg) , propofol (2 mg/kg), rocuronium (0.6 mg/kg)





Maintained: fentanyl (3 μg.kg−1), propfol (6–7 mg.kg−1.h−1);
rocuronium (0.5 mg.kg−1.h−1)
G-TIVA-TEA: T6-T7 or T7-T8 epidural with initial 6–8 ml
bupivacaine, then induced: same as G-TIVA group
Maintained: 0.375 % bupivacaine (6–7 mL.h−1), propofol
(6–7 mg.kg−1.h−1), rocuronium (0.6 mg/kg)
Jung et
al. [8]
13G-TIVA G-TIVA: induced: fentanyl (50–100 μg), propofol (4–5 μg/ml),
vecuronium (0.1 mg.kg−1)
hemodynamic variables: HR, MAP, CVP. MPAP, PAOP, CO,
SVR, PVR; Intrapulmonary shunt: PvO2,PaO2,Qs/Qt,PaCO2, PH,
SvO2,SaO2; Other: Hb, Paw13G-TIVA-
TEA-B
Maintained: 20 μg/ml remifentanil, 0.2 ml.kg−1.h−1;
vecuronium (2–2.5 mg..h−1), propofol (according to BIS)
13G-TIVA-
TEA-S
G-TIVA-TEA-B: T5-T6 or T6-T7 epidural with initial 10 ml 5 %
bupivacaine, then induced: same as G-TIVA group.
Maintained: 0.25 % bupivacaine 0.1 ml.kg−1.h−1, propofol
(6–7 mg.kg−1.h−1), vecuronium (2–2.5 mg..h−1), propofol
(according to BIS)
G-TIVA-TEA-S: T5-T6 or T6-T7 epidural with initial 10 ml 50 μg
sufentanil , then induced :same as G-TIVA group
Maintained: 1 μg/ml sufentanil 0.1 ml.kg−1.h−1), propofol




37 G-TIVA G-TIVA: induced: fentanyl (3 μg.kg−1), midazolam (0.04 mg/kg),
propofol (2 mg/kg), rocuronium (0.6 mg.kg−1)
hemodynamic variables: HR, MAP; Intrapulmonary shunt:
PvO2,PaO2,Qs/Qt,PaCO2, PH,SvO2,SaO2,CaO2,CvO2; Other:
Hb, Paw




G-TIVA-TEA: T6-T7 or T7-T8 epidural with initial meperidine
2 mg.kg−1 diluted in avolume of 10–12 mL, then induced :same
as G-TIVA group





25 G-TIVA G-TIVA: induced: fentanyl (5–10 μg.kg−1), thiopental
(3–5 mg.kg−1), panccuronium (0.1 mg.kg−1)




Maintained: fentanyl (5–10 μg.kg−1.h−1), propfol
(6–10 mg.kg−1.h−1), panccuronium(0.05–0.15 mg.kg−1)
G-TIVA-TEA: T6–7 or T7–8 epidural with initial 0.5 % bupivacaine
15 mg, then induced the same as G-TIVA group
Maintained: 0.5 % bupivacaine (range 15–25 mg), propfol




12G-TIVA G-TIVA: induced :fentanyl (3 μg.kg−1), propfol (1 mg.kg−1) ,
Vecuronim (0.1 mg.kg−1)
hemodynamic variables; HR, MAP, MPAP, CVP, CO;
Intrapulmonary shunt: PaO2, PaCO2, Qs/Qt
Maintained: propfol (9–12 mg.kg−1.h−1), Vecuronim (0.1 mg.kg−1),
T7–8 or T8–9 epidural with initial 1 % lidocaine 5 ml ,then
maintained with normal saline 5 ml/h
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Table 1 Included randomized controlled trials for effects of thoracic epidural analgesia on oxygenation and pulmonary shunt
fraction during One-lung ventilation (Continued)
12G-TIVA-
TEA
G-TIVA-TEA: T7–8 or T8–9 epidural with initial 0.5 % ropivacaine
7–9 ml, then induced the same as G-TIVA group.
Maintaine with epidural ropivacaine 3–5 ml.h−1 combined with
propfol (4.8–7.2 mg.kg−1.h−1), Vecuronim (0.1 mg.kg−1)
Lu JH et
al. [12]
10 G-SEV G-SEV: induced: fentanyl (100 μg ), propfol (2 mg.kg−1),
vecuronim (0.1 mg.kg−1)
Intrapulmonary shunt: PaO2, PaCO2, PETCO2; Other: Hb, Paw
10 G-SEV-
TEA
Maintained: 0.5–1.3 MAC sevofrane, panccuronium (not mentioned)
G-SEV-TEA: T5–6 or T6–7 epidural with initial 1.0 %
lidocaine 5 ml then induced as G-SEV.
Maintained: epidural with 1.0 % lidocaine 5 ml.45mins−1,




30 G-TIVA G-TIVA: induced: fentanyl (2 μg.kg−1), midazolam (0.1 mg.kg-1),
propfol (1.2–2.0 mg.kg−1) , vecuronim (0.1 mg.kg−1)
Intrapulmonary shunt: PaO2, PaCO2, Qs/Qt
30G-TIVA-
TEA
Maintained: fentanyl (0.2 μg.kg−1.h−1), propfol
(3–6 mg.kg−1.h−1), vecuronium(0.05 mg.kg−1)
G-TIVA-TEA: T6–7 epidural with initial 1.0 % lidocaine 5 ml
then induced as G- TIVA.
Maintained: epidural with 1.0 % lidocaine mixed with 0.25 %




16 G-ISO G-ISO: induced: fentanyl (2 μg.kg−1), midazolam (0.1 mg.kg-1),
propfol (1.0–2.0 mg.kg−1), vecuronim (0.16 mg.kg−1)
hemodynamic variables: HR, MAP; Intrapulmonary shunt:
PaO2, PaCO2, PvO2, Qs/Qt
14 G-ISO-
TEA
Maintained: isoflurane (2.0–4.0MAC), fentanyl (50 μg)
G-ISO-TEA: T6–7 or T7-8epidural with initial 2.0 % lidocaine
3 ml then induced as G- ISO.
Maintained: epidural with 0.5 % bupivacaine 5 ml.h−1,
combined with propfol (4–6 mg.kg−1.h−1)
Wang et
al. [15]
15 G-ISO G-ISO: induced: fentanyl (2 μg.kg−1), midazolam (0.05 mg.kg-1),
propfol (1.5–2.0 mg.kg−1), vecuronim (0.1 mg.kg−1)
hemodynamic variables: HR, MAP; Intrapulmonary shunt:
PaO2/Fio2, Qs/Qt Other: Paw
15 G-ISO-
TEA
Maintained: isoflurane (0.5–1.3MAC), vecuronim (not mentioned)
G-ISO-TEA: T10–11 epidural with initial 0.5 % lidocaine then
induced as G- ISO.
Maintained: epidural with 0.5 % lidocaine 5 ml.h−1, combined
with isoflurane (0.5–1.3MAC), vecuronim (not mentioned)
Chen et
al. [16]
13 G-TIVA G-TIVA: induced: fentanyl (3 μg.kg−1), midazolam (0.1 mg.kg-1),
propfol (1.0–2.0 mg.kg−1), vecuronim (0.1 mg.kg−1)
hemodynamic variables; HR, MAP; Intrapulmonary shunt:




Maintained: fentanyl (0.2 μg.kg−1.h−1), propfol
(3–6 mg.kg−1.h−1), vecuronium(0.05 mg.kg−1)
G-TIVA-TEA: T6–7 epidural with initial 1.0 % lidocaine mixed with
0.375 % bupivacaine 8–10 ml then induced as G- TIVA.
Maintained: epidural with mixture of lidocaine and bupivacaine




41G-TIVA G-TIVA: induced: midazolam (0.05 mg.kg-1), fentanil, propfol
and vecuronim (no details)




Maintained: fentanil, propfol and vecuronium (no details,
according to BIS).
G-TIVA-TEA: T5–6 or T6–7 epidural with initial 0.5 % ropivacaine
7–12 ml then induced as G- TIVA.
Maintained: epidural with 0.5 % ropivacaine 4–5 ml.h−1,
combined with propfol and vecuronium (no details).
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by different medications in epidural catheter of TEA
group or different anesthetic regimens in GA group.
Quantitative analyses were performed using Review
Manager Software (version 5.0; Cochrane Collaboration,
Oxford shire, England). The level of significance for all
tests is set at a α level of 0.05. For dichotomous data,
Petro odds ratios (ORs) with 95 % confidence intervals
(CIs) were computed. When possible, data were con-
verted to means and standard deviations (SD) for con-
tinuous outcomes and calculated as weighted mean
differences with 95 % CIs between active and control
groups for each study. For heterogeneity analyses: data
that were not significantly homogeneous (P > 0.1) were
analyzed with a fixed-effect model, whereas heterogeneous
data (P ≤ 0.1) were analyzed with a random effect model.
Sensitivity analyses were performed to identify sources of
heterogeneity. Studies which do not report mean and SD
or standard error of the mean (SEM) are not included in
the meta-analysis.
Results
Retrieved and included studies
Fourteen reports were retrieved while one trial with self-
comparison was rejected (Fig. 1). A total of 653 patients
with 60 separate comparisons met all inclusion criteria [5,
6, 8–19] (Table 1). These reports were published between
Table 1 Included randomized controlled trials for effects of thoracic epidural analgesia on oxygenation and pulmonary shunt




43G-TIVA G-TIVA: induced: midazolam (0.05 mg.kg-1), fentanil,
propfol and vecuronim (no details)




Maintained: fentanil, propfol and vecuronium
(no details, according to BIS).
G-TIVA-TEA: T5–6 or T6–7 epidural with initial 0.5 %
ropivacaine 7–12 ml then induced as G- TIVA.
Maintained: epidural with 0.5 % ropivacaine 4–6 ml.h−1,





G-ISO-TEA and G-TIVA-TEA: induced: T7–8 or T8–9 epidural with
initial 0.5 % ropivacaine 7–9 ml then induced with fentanyl
(3 μg.kg−1), midazolam (2-3 mg), propfol (1.5 mg.kg−1),
vecuronim (0.1 mg.kg−1)




Maintained: isoflurane and propfol
respectively(no details, according to BIS).
TEA thoracic epidural anesthesia with local anesthetic, opioids or both, TIVA total-intravenous anesthesia, ISO isoflurane inhalation anesthesia
Fig. 1 The flow diagram of retrieved, excluded, and analyzed trials. * Cochrane Central Register of Controlled Trials. †Continuous data presented
as means but without standard deviation, no dichotomous data. RCT indicates randomized controlled trials
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1999 and 2010 and reported data were from 653 patients.
Forty one studies were excluded: 1) not thoracic surgery; 2)
no available data on observed indexes; 3) the intervention
used in studies not consistent with the criteria.
Among included trials, the epidural catheter was all
placed at T6–7, T7–8 or T8–9 interspace in the TEA group
and continuously injected with local anesthetics, opioids
or both via the catheter during the whole OLV proced-
ure more than 30 min. Controls received intravenous
opioids with or without nonopioid analgesics (Table 1).
Risk of bias in included studies
Overall study quality was moderate. There was adequate
randomization in 10/14 (71.4 %) of studies, double-
blinding in 12/14 (85.7 %) of studies and statement of
withdraw in 3/14 (21.4 %) of studies. Three studies were
assessed all in three domains and five studies were
assessed in two domains.
Thoracic Epidural analgesia on systemic hemodynamics
variables
Overall, it was shown that TEA did not significantly
affect the changes of hemodynamic variables during two
lung ventilation, and it is associated with significantly re-
duction in heart rate (HR) and systemic vascular resist-
ance (SVR) only during OLV within 30 min. However,
there was a continuously significant decrease in mean
arterial pressure (MAP) and mean pulmonary arterial
pressure (MPAP) during the whole OLV period until re-
two lung ventilation (re-TLV) (Table 2).
Thoracic Epidural analgesia on oxygenation and
pulmonary shunt fraction variables
It was shown that TEA did not significantly affect the pul-
monary shunt fraction during TLV. From TLV to OLV,
TEA modestly reduced arterial oxygen pressure (PaO2),
mixed arterial saturation of oxygenation (SaO2) and in-
creased the pulmonary venous admixture fraction (Qs/
Qt%) and mean airway pressure (Paw) occurred during
OLV. A decrease in mixed venous saturation of oxygen-
ation (SvO2) occurred after 30 min of OLV (Fig. 2, Table 3).
To overcome clinical heterogeneity, data were pooled
for sensitivity analysis between different techniques of
general anesthesia (e.g. total intravenous anesthesia vs.
balanced anesthesia) and types of medications in epi-
dural catheter of TEA group. There were no obviously
differences in all observed variables. However, no pool-
ing of data from epidural anesthesia with different local
anesthetics was possible for small number of studies.
Discussion and conclusions
The anesthetic technique is one of several factors that
can affect oxygenation and hemodynamics during one-
lung ventilation (OLV), among which thoracic epidural
analgesia (TEA) has demonstrated to provide statistically
better acute pain relief after thoracotomy and now
widely used in clinic [2, 3]. However, there were few and
contradictory studies considering the effects of TEA on
hemodynamics and oxygenation changes during the pro-
cedure of OLV [5, 6, 9]. This is the first meta-analysis
comparing the effects of TEA on oxygenation and pul-
monary shunt fraction during OLV. The most significant
finding of our meta-analysis is an equivalent effect of
combining TEA with any technique of general anaesthe-
sia (GA) on hemodynamic and oxygenation variables in
patients undergoing OLV after re-conversion to TLV in
supine position, having positive effects on patient safety
during surgery. However, the current study demon-
strates that TEA inhibited hypoxic pulmonary vaso-
constriction (HPV) as producing larger shunt
fractions and lower PaO2, accompanied with de-
creased systemic hemodynamics compared with GA
after undergoing OLV for more than 30 min. It is
consistent with recent studies, in which the authors
showed that, an increase in Qs/Qt was accompanied
with a decrease in PaO2, but cardiac output (CO)
and pulmonary artery pressure (PAP) were preserved
between the groups [7, 20, 21]. At the same time,
TEA was found to be associated with lower MPAP in
line with decreased MAP and SVR, whereas CO was
comparable. Ephedrine is a partial α-and ß-agonist.
All trials included in our meta-analysis showed a ten-
dency towards lower mean arterial blood pressure in
the TEA group, which was treated by administering a
dose of 5 or 10 mg ephedrine intravenously. Mechan-
ism leading to less marked effects on CO was attrib-
uted to the higher incidence of ephedrine use in TEA
groups. It had significant vasopressor activity in the
pulmonary vascular bed that predominantly mediated
by α-adrenergic receptor activation, although ephe-
drine dose less than 0.15 mg/kg did not increase the
intrapulmonary shunt during OLV [8, 10]. Addition-
ally, increasing in HR and ventricular contractility
strengthen by ß-adrenergic subtype activation in left
ventricular tissue could also explain the similarity of
the compared values of CO [10]. Hence, the decrease
in oxygenation was secondary to the effect of TEA on
HPV and probably not on the changes of CO.
The pulmonary vasculature is dominant in sympa-
thetic activity by the norepinephrine released from sym-
pathetic nerve endings [6, 9, 22]. Potential mechanism of
the influence of pulmonary shunt fraction during OLV
was prone to cardiovascular and hemodynamic effects of
TEA. Decrease in HR, MAP, stoke volume due to block-
ade of sympathetic activity over the vascular pulmonary
responses was shown closely associated with decreased
PaO2 [6, 9]. The decreased PaO2 may further have an
opposite effects on HPV [5, 6, 23]. It may produce
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vasodilatation of the pulmonary vessels by blocking the
activity of the thoracic sympathetic response [24] or
stimulate precapillary vasoconstriction via a pathway in-
volving NO and/or cyclooxygenase synthesis inhibition
[17]. In an animal study by Ishibe, TEA was demon-
strated to affect the ventilation/reperfusion relationship
by stimulating precapillary vasoconstriction to redistrib-
ute pulmonary blood flow away from hypoxemic lung
regions to the other well oxygenated areas of the lung
[7], which was consistent with the study of Garutti I [6].
However, similar but significant differences in magni-
tude of changes in pulmonary hemodynamic circulation
accorded with systemic in both groups may contribute
to the analgesic effect of TEA or the systemic effects of
the absorption of the local anesthetics for overall
reduced sympathetic tone, and blockade of cardiac accel-
erator fibers [6]. The principal weakness of our meta-
analysis is that we combined data for comparison even
with some studies which were heterogeneous such as
epidural treatments with different drugs (e.g. local
Table 2 Effects of thoracic epidural analgesia on hemodynamics variables during OLV
Median of Means (Range)
All available data No. of comparisons TEA group GA group WMD (95 % CI) P value
During two-lung ventilation
HR(beat / min) 7 72.98 (68.80 to 83.00) 73.71 (69.00 to 78.00) −1.33 [−5.16 to 2.50] 0.50
MAP(mmHg) 5 83.62 (76.00 to 87.00) 86.26. (75.00 to 93.00) −2.28 [−5.51 to 0.95] 0.17
CO (L/min) 2 5.50 (5.20 to 5.80) 4.90 (4.90 to 4.90) 0.55 [−0.21 to 1.30] 0.16
CVP (cmH2O) 3 7.00 (6.00 to 8.00) 8.00 (6.00 to 9.00) −1.00 [−3.94 to 1.95] 0.51
SVR (dynes · sec · cm−5) 3 1180.70(1022.00 to 1308.00) 1401.67(1395.00 to 1405.00) −246.16[−408.55 to -83.77] 0.29
MPAP (mmHg) 3 20.67 (18.00 to 22.00) 18.67 (18.00 to 19.00) 2.09 [−0.94 to 5.13] 0.18
PAOP(mmHg) 2 12.50 (12.00 to 13.00) 13.00 (13.00 to 13.00) −0.59 [−2.48 to 1.31] 0.55
During one-lung ventilation within 30 min
HR(beat / min) 7 74.14 (66.00 to 85.00) 75.48 (73.20 to 80.00) −3.28 [−5.89 to −0.67] 0.01
MAP(mmHg) 7 85.11 (81.00 to 89.00) 93.29 (87.60 to 100.00) −6.64 [−9.57 to −3.71] <0.01
CO (L/min) 2 5.40 (5.40 to 5.40) 5.70 (5.70 to 5.70) −0.30 [−1.15 to 0.55] 0.49
CVP (cmH2O) 3 8.30 (7.00 to 10.00) 9.00 (8.00 to 11.00) −0.61 [−1.72, 0.49] 0.28
SVR (dynes · sec · cm−5) 3 1003.33(890.00 to 1124.00) 1349.67(1141.00 to 1454.00) −319.99[−447.05 to -192.94] <0.01
MPAP (mmHg) 3 20.00 (19.00 to 22.00) 23.00 (23.00 to 23.00) −3.18 [−5.07 to −1.28] <0.01
PAOP(mmHg) 2 12.00 (12.00 to 12.00) 13.00 (13.00 to 13.00) −1.00 [−2.87 to 0.87] 0.30
One-lung ventilation more than 30 min
HR(beat / min) 6 76.00 (75.00 to 87.00) 75.32 (71.50 to 80.00) −0.94 [−3.81 to 1.92] 0.52
MAP(mmHg) 6 84.12 (75.00 to 87.00) 91.85 (85.80 to 98.00) −6.33 [−9.25 to −3.41] <0.01
CO (L/min) 4 5.55 (4.70 to 6.10) 5.55 (5.50 to 5.60) −0.07 [−0.64 to 0.51] 0.82
CVP (cmH2O) 4 7.75 (7.00 to 9.00) 8.00 (7.00 to 9.00) −0.37 [−1.24 to 0.51] 0.41
SVR (dynes · sec · cm−5) 4 1168.50(981.00 to 1356.00) 1209.00(1209.00 to 1209.00) −38.17[−201.75 to 125.42] 0.07
MPAP (mmHg) 4 20.00 (18.00 to 21.00) 22.50 (22.00 to 23.00) −2.05 [−3.35 to −0.75] <0.01
PAOP(mmHg) 4 12.50 (12.00 to 13.00) 13.50 (13.00 to 14.00) −1.11 [−2.40 to 0.18] 0.09
Re-two ventilation
HR(beat / min) 5 74.40 (65.00 to 87.00) 71.60 (67.00 to 78.00) −0.41 [−4.08 to 3.25] 0.82
MAP(mmHg) 5 84.40 (81.00 to 87.00) 95.80 (92.00 to 95.00) −11.83 [−15.87 to −7.79] <0.01
CO (L/min) 2 5.55 (5.50 to 5.60) 5.20 (5.20 to 5.20) 0.35 [−0.58 to 1.29] 0.46
CVP (cmH2O) 3 7.67 (7.00 to 9.00) 6.33 (6.00 to 7.00) 1.20 [−0.15 to 2.55] 0.08
SVR (dynes · sec · cm−5) 3 1157.00(1052.00 to 1316.00) 1358.67(1226.00 to 1425.00) −186.69[−312.37 to −61.01] <0.01
MPAP (mmHg) 3 19.67 (18.00 to 21.00) 21.33 (21.00 to 22.00) −1.77 [−3.61 to 0.07] 0.06
PAOP(mmHg) 2 11.00 (10.00 to 12.00) 12.00 (12.00 to 12.00) −1.03[−2.75 to 0.68] 0.24
Data were presented as Mean and rang in bracket
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anesthetics, opioids etc.) or different patient population.
On the other hand, more significant differences might
attain when better designed published trails with large
sample size become available.
Another main reason for failing to show the beneficial
effect of TEA during OLV was that in clinical circum-
stances, there were several other factors affecting HPV
in different direction, finally resulting in clinically signifi-
cant net effects. In our study, TEA was associated with
higher mean airway pressure in the dependent lung
compared with GA, which may counteract HPV in the
non-dependent lung by diverting blood flow away from
the ventilated lung, thereby increasing the pulmonary
shunt. Besides, the decreased SvO2 in the TEA after
30 mins of OLV in addition to changes in shunt fraction
may better explain the mechanism of our obverted oxy-
genation changes. Furthermore, there is essentially un-
charged PaCO2 in both groups. Though, the efficacy of
HPV in hypoxic lung regions is increased in the pres-
ence of respiratory acidosis and inhibited by respiratory
Fig. 2 Effect of thoracic epidural analgesia (TEA) on pulmonary venous admixture fraction (Qs/Qt) in general anesthesia (GA) combined with TEA
group and GA group during mechanical ventilation: Forest plot showing pooled analysis of the WMD of Qs/Qt in two groups during two-lung
ventilation (01), one-lung ventilation within 30 min (02), one-lung ventilation more than 30 min (03) and re-two-lung ventilation (04) based on
the fixed effects model. CI = confidence interval
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alkalosis. There is no net benefit to exchange gas dur-
ing OLV from hypoventilation for the hypercapnia. It
seems to act as a vasoconstrictor by selectively in-
creasing ventilated lung pulmonary vascular resistance
(enhanced directly regional HPV) during OLV [25].
Additional, patients having right-sided thoracotomies
tend to have a larger shunt and lower PaO2 during
OLV. This is because the right lung is larger and
normally better perfused than the left [26]. The un-
warranted effects of higher FiO2 ratios have been
shown to atelectasis even after very short periods of
ventilation [27, 28]. There were no observed signifi-
cant differences in the other oxygenation or
hemodynamic variables in our study.
Table 3 Effects of thoracic epidural analgesia on oxygenation and pulmonary shunt fraction variables during OLV
Median of Means (Range)
All available data No. of comparisons TEA group GA group WMD (95 % CI) P value
During two-lung ventilation
PaO2 (mmHg) 13 382.42(205.00 to 85.00) 377.92(191.0 to 453.00) 6.29 [0.04 to 12.17] 0.35
PaCO2 (mmHg) 10 39.67 (32.50 to 37.6) 40.23 (35.60 to 37.40) −0.21 [−1.11 to 0.68] 0.64
PvO2 (mmHg) 7 51.50(48.00 to 55.0) 51.62(48.0 to 53.30) 0.27 [−1.51 to 2.06] 0.76
Qs/Qt (%) 13 14.80 (4.90 to 22.50) 15.50 (3.95 to 21.60) 0.02[−0.47 to 0.50] 0.95
SvO2 (%) 4 85.37(83.30 to 87.10) 86.68(84.90 to 88.20) −1.22[−2.36 to −0.07] 0.58
SaO2 (%) 4 99.75(99.70 to 99.90) 99.45(99.00 to 99.90) −0.06[−0.08 to −0.04] 0.30
PH 4 7.43 (7.42 to 7.43) 7.44 (7.43 to 7.44) −0.01 [−0.02 to 0.00] 0.21
Paw (cmH2O) 4 18.63 (17.00 to 20.00) 19.03 (17.00 to 21.40) −0.24 [−1.14 to 0.66] 0.60
During one-lung ventilation within 30 min
PaO2 (mmHg) 10 166.90(118.00 to 211.00) 171.2(122.00 to 201.00) −16.52[−21.98 to -11.05] <0.01
PaCO2 (mmHg) 10 37.12 (36.10 to 44.20) 36.85(34.20 to 42.20) 0.29 [−0.53 to 1.10] 0.49
PvO2 (mmHg) 7 47.78(44.90 to 54.00) 46.14(44.50 to 51.00) 1.13 [−0.50 to 2.76] 0.17
Qs/Qt (%) 10 33.32 (27.30 to 39.50) 32.77 (26.70 to 40.60) 2.53 [1.35 to 3.72] <0.01
SvO2 (%) 4 80.53(78.30 to 82.60) 81.58(78.40 to 84.20) −1.13[−2.74 to 0.48] 0.17
SaO2 (%) 4 97.98(96.80 to 99.30) 97.65(97.30 to 98.00) 0.74[0.33 to 1.15] <0.01
PH 4 7.43 (7.42 to 7.44) 7.44 (7.42 to 7.46) −0.01 [−0.02 to 0.001] 0.41
Paw (cmH2O) 4 28.00 (23.00 to 32.50) 27.00 (24.00 to 30.90) 1.95 [1.61 to 2.28] <0.01
One-lung ventilation more than 30 min
PaO2 (mmHg) 11 162.27(117.00 to 203.00) 168.72(148.00 to 221.00) −14.23[−20.81 to -7.65] <0.01
PaCO2 (mmHg) 11 36.61 (33.90 to 44.60) 36.78 (35.00 to 44.20) −0.22 [−0.96 to 0.53] 0.57
PvO2 (mmHg) 6 44.70(42.60 to 46.10) 44.98(43.40 to 46.60) −0.61[−2.23 to 1.02] 0.46
Qs/Qt (%) 12 34.40 (33.60 to 42.70) 32.67 (32.10 to 40.90) 2.77 [1.81 to 3.74] <0.01
SvO2 (%) 6 79.33(77.40 to 81.10) 81.97(78.50 to 83.90) −2.39[−3.73 to −0.99] <0.01
SaO2 (%) 6 97.68(96.60 to 98.10) 98.20(97.20 to 99.00) −0.63[−1.23 to −0.04] 0.04
PH 6 7.43 (7.43 to 7.44) 7.44 (7.41 to 7.46) 0.00 [−0.01 to 0.01] 0.50
Paw (cmH2O) 6 26.80 (24.00 to 32.50) 26.72 (24.00 to 31.40) 0.87 [0.54 to 1.20] <0.01
Re-two ventilation
PaO2 (mmHg) 7 322.28(173.00 to 482.00) 307.28(168.00 to 407.00) 11.54[−4.25 to 27.34] 0.15
PaCO2 (mmHg) 3 37.8 (34.00 to 46.10) 35.6 (34.90 to 36.90) −0.60 [−3.03 to 1.83] 0.63
PvO2 (mmHg) 5 47.82(43.00 to 50.00) 48.68(46.20 to 51.00) 0.06[−2.24 to 2.36] 0.96
Qs/Qt (%) 6 18.55(15.30 to 24.50) 20.15(15.50 to 24.80) −1.27 [−2.73 to 0.20] 0.09
SvO2 (%) 2 81.90(81.50 to 82.30) 85.30(85.30 to 85.30) −3.62[−6.28 to −0.95] 0.80
SaO2 (%) 2 99.75(99.70 to 99.80) 99.00 (99.00 to 99.00) 0.75[0.52 to 0.98] 0.67
PH 2 7.42 (7.41 to 7.42) 7.42 (7.42 to 7.42) 0.00 [−0.03 to 0.02] 0.77
Paw (cmH2O) 2 19.00 (18.00 to 20.00) 18.00 (18.00 to 18.00) 0.95 [−0.81 to 2.71] 0.29
Data were presented as Mean and rang in bracket
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Some limitations are inherent to our meta-analysis.
Firstly, it is possible we have missed trial that satisfied
the inclusion criteria, and some data have to be excluded
as the reports are incomplete. Secondly, the quality of
the randomized trials in the systemic review is varied. So
few alternative protocols with small sample sizes have
been studied in effects of TEA on oxygenation and pul-
monary shunt fraction during OLV, and quantitative
analyses were limited as a result of heterogeneity and
outcomes measures. Epidural thoracic anesthesia can be
performed with LA, opioids or both, which limits the
studies with homogeneous design from which data can
be pooled. The sensitivity analyses were only chosen ac-
cording to the different anesthetic regimens of GA
group, although it is unlikely that different subgroups
would have changed our findings, such as re-subgrouped
by the different medication of TEA group, use of right
arterial blood samples instead of pulmonary arterial
blood [5, 29] or different sympathetic block level.
Thirdly, the time intervals for outcome assessments
were chosen with principle of the greatest degree of in-
clusion. Although the findings are reported as statisti-
cally significant, they are very discrete in clinical terms.
It might be a possibility of different results because dif-
ferent measurements were evaluated after OLV, but it is
still difficult to draw definite conclusions until further
large, well conducted trials are performed.
Nevertheless, the analyses performed with limited
studies allowed us to put forward recommendations for
cautious usage of TEA in counteracting HPV undergo-
ing OLV by producing a larger shunt and a decrease in
oxygenation during the OLV as the vasodilatation caused
by sympathetic blockade.
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